JPH06505749A - 1,4−置換ピペリジンの誘導体に基づく新規液体組成物 - Google Patents
1,4−置換ピペリジンの誘導体に基づく新規液体組成物Info
- Publication number
- JPH06505749A JPH06505749A JP50750292A JP50750292A JPH06505749A JP H06505749 A JPH06505749 A JP H06505749A JP 50750292 A JP50750292 A JP 50750292A JP 50750292 A JP50750292 A JP 50750292A JP H06505749 A JPH06505749 A JP H06505749A
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- formula
- polyethylene glycol
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (6)
- 1.式 3▲数式、化学式、表等があります▼ [式中: −R1はチエニル基、場合によりハロゲンにより置換されたフェニル基、炭素数 が1−6のアルコキシ基又は炭素数が1−6のアルキル基を示し、 −R2はハロゲン原子、水素原子、炭素数が1−6のアルコキシ基又は炭素数が 1−6のアルキル基を示し、−R3はハロゲン原子、水素原子、炭素数が1−6 のアルコキシ基、炭素数が1−6のアルキル基、炭素数が1−6のアルキルチオ 基、炭素数が5−6のシクロアルキル基又は式 ▲数式、化学式、表等があります▼ の基を示し、ここでR4及びR5は互いに独立して水素原子又は炭素数が1−6 のアルキル基を示し、R6は炭素数が3−6のシクロアルキル基、ヒドロキシメ チル又はカルボキシル基、又は炭素数が2−7のアルコキシカルボニル基を示し 、 −Wはカルボニル又はヒドロキシメチレン基を示す]に対応する化合物に基づき 、組成物が可溶化剤を含んで界面活性剤を含まないことを特徴とする液体製薬学 的組成物。
- 2.活性化合物が式(I) [式中、 −R1がフェニル基を示し、 −R2が水素を示し、 −R3がtert−ブチル基を示し、 −Wがカルボニル基を示す] に対応することを特徴とする請求の範囲1に記載の組成物。
- 3.可溶化剤がポリエチレングリコールであることを特徴とする請求の範囲1に 記載の組成物。
- 4.ポリエチレングリコールがポリエチレングリコール600であることを特徴 とする請求の範囲3に記載の組成物。
- 5.式(I)の化合物に対するポリエチレングリコールの重量比が100−50 0、好ましくは100−200であることを特徴とする請求の範囲3に記載の組 成物。
- 6.組成物が −0.1の式(I)の化合物、 −pHを約4.2に調節する量の乳酸 −16%のポリエチレングリコール −60%の甘味料 を含み、100%までの補足が水であらことを特徴とする請求の範囲1−5のい ずれか1つに記載の組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR91/03049 | 1991-03-13 | ||
FR9103049A FR2673842B1 (fr) | 1991-03-13 | 1991-03-13 | Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4. |
PCT/FR1992/000215 WO1992016210A1 (fr) | 1991-03-13 | 1992-03-10 | Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06505749A true JPH06505749A (ja) | 1994-06-30 |
JP3469576B2 JP3469576B2 (ja) | 2003-11-25 |
Family
ID=9410697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50750292A Expired - Fee Related JP3469576B2 (ja) | 1991-03-13 | 1992-03-10 | 1,4−置換ピペリジンの誘導体に基づく新規液体組成物 |
Country Status (13)
Country | Link |
---|---|
US (1) | US5602148A (ja) |
EP (1) | EP0575481B1 (ja) |
JP (1) | JP3469576B2 (ja) |
AT (1) | ATE138572T1 (ja) |
CA (1) | CA2103667C (ja) |
DE (1) | DE69211127T2 (ja) |
DK (1) | DK0575481T3 (ja) |
ES (1) | ES2087534T3 (ja) |
FR (1) | FR2673842B1 (ja) |
GR (1) | GR3020075T3 (ja) |
HK (1) | HK1006282A1 (ja) |
PT (1) | PT100241B (ja) |
WO (1) | WO1992016210A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2107375B1 (es) * | 1995-08-01 | 1998-07-01 | Almirall Prodesfarma Sa | Formulaciones farmaceuticas liquidas de ebastina por via oral. |
CA2478897A1 (en) * | 2002-03-12 | 2003-09-18 | Y's Therapeutics Co., Limited | Compounds capable of inhibiting immunocyte-related allergic immune reactions |
US20070059371A1 (en) * | 2005-06-09 | 2007-03-15 | Elan Pharma International, Limited | Nanoparticulate ebastine formulations |
US7367847B2 (en) * | 2005-09-02 | 2008-05-06 | Alcoa Fujikura Ltd | Integrated module connection for HEV battery |
WO2013081562A1 (en) | 2011-10-13 | 2013-06-06 | Mahmut Bilgic | Oral formulations comprising ebastine |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4666905A (en) * | 1983-06-02 | 1987-05-19 | Warner-Lambert Company | Diphenylmethylene piperidines compositions and methods for their use |
GB8321157D0 (en) * | 1983-08-05 | 1983-09-07 | Fordonal Sa | Piperidine derivatives |
US4871733A (en) * | 1984-04-09 | 1989-10-03 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
US4783465A (en) * | 1984-04-09 | 1988-11-08 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
US4975426A (en) * | 1987-06-08 | 1990-12-04 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
US4829064A (en) * | 1987-06-08 | 1989-05-09 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
EP0345931B1 (en) * | 1988-04-27 | 1993-01-20 | Schering Corporation | Certain paf antagonist/antihistamine combinations and methods |
-
1991
- 1991-03-13 FR FR9103049A patent/FR2673842B1/fr not_active Expired - Fee Related
-
1992
- 1992-03-10 ES ES92907934T patent/ES2087534T3/es not_active Expired - Lifetime
- 1992-03-10 EP EP92907934A patent/EP0575481B1/fr not_active Expired - Lifetime
- 1992-03-10 DK DK92907934.1T patent/DK0575481T3/da active
- 1992-03-10 WO PCT/FR1992/000215 patent/WO1992016210A1/fr active IP Right Grant
- 1992-03-10 CA CA002103667A patent/CA2103667C/fr not_active Expired - Lifetime
- 1992-03-10 DE DE69211127T patent/DE69211127T2/de not_active Expired - Lifetime
- 1992-03-10 AT AT92907934T patent/ATE138572T1/de not_active IP Right Cessation
- 1992-03-10 JP JP50750292A patent/JP3469576B2/ja not_active Expired - Fee Related
- 1992-03-13 PT PT100241A patent/PT100241B/pt not_active IP Right Cessation
-
1995
- 1995-02-21 US US08/391,286 patent/US5602148A/en not_active Expired - Lifetime
-
1996
- 1996-05-30 GR GR960400016T patent/GR3020075T3/el unknown
-
1998
- 1998-06-17 HK HK98105461A patent/HK1006282A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GR3020075T3 (en) | 1996-08-31 |
FR2673842B1 (fr) | 1993-12-24 |
PT100241B (pt) | 1999-06-30 |
EP0575481B1 (fr) | 1996-05-29 |
CA2103667A1 (fr) | 1992-09-14 |
DE69211127D1 (de) | 1996-07-04 |
WO1992016210A1 (fr) | 1992-10-01 |
ATE138572T1 (de) | 1996-06-15 |
JP3469576B2 (ja) | 2003-11-25 |
CA2103667C (fr) | 2005-08-30 |
DK0575481T3 (da) | 1996-07-01 |
ES2087534T3 (es) | 1996-07-16 |
DE69211127T2 (de) | 1996-10-10 |
PT100241A (pt) | 1994-05-31 |
US5602148A (en) | 1997-02-11 |
FR2673842A1 (fr) | 1992-09-18 |
HK1006282A1 (en) | 1999-02-19 |
EP0575481A1 (fr) | 1993-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2515788B2 (ja) | 目の炎症の治療薬 | |
JP2703906B2 (ja) | 酸化に対して安定化された薬剤組成物 | |
JP2588686B2 (ja) | 高脂血症及び動脈硬化症の予防・治療薬 | |
HU197840B (en) | Process for producing synergic pharmaceutical compositions comprising amantadin and selegilin | |
RU2204387C2 (ru) | Фармацевтические композиции | |
JPH1160505A (ja) | 防腐組成物 | |
JP2003505419A (ja) | ケトチフェンを含む眼用組成物 | |
CZ297788B6 (cs) | Farmaceutický prostredek pro parenterální podání | |
US3922340A (en) | Pharmaceutical compositions for treating lung diseases | |
JPH06505749A (ja) | 1,4−置換ピペリジンの誘導体に基づく新規液体組成物 | |
MXPA02009336A (es) | Solucion parenteral que contiene amiodarona. | |
JP5314014B2 (ja) | テルビブジンを含む医薬内用液 | |
WO2007004523A1 (ja) | L-アルギニン含有医薬組成物及び飲食品用組成物 | |
US4143151A (en) | Method for treating hyperglycemia in mammals using arylamino benzoic acids | |
HU198381B (en) | Process for production of parenteralic solutions | |
US5276044A (en) | Leukotriene receptor antagonist and antihistamine complex pharmaceutical compositions | |
JPS62132826A (ja) | 抗高血圧剤 | |
CZ431399A3 (cs) | Způsob výroby farmaceutického prostředku | |
KR102556874B1 (ko) | 비스포스포네이트 및 콜레칼시페롤을 함유하는 경구용 에멀젼 조성물 및 그 제조방법 | |
CA2417258A1 (en) | Flavoring systems for pharmaceutical compositions and methods of making such compositions | |
JP6014252B2 (ja) | ネパデュタントを含有する小児用経口液体組成物 | |
JPH02221213A (ja) | 皮膚化粧料 | |
US2694664A (en) | Choline and inositol preparation containing a surface-active agent | |
KR0169402B1 (ko) | 티아졸리딘 2,4-디카르복실산 아르기닌염(아르기닌티디아시케이트)함유액제 및 그의 제조방법 | |
KR100754953B1 (ko) | 유비데카레논을 함유한 가용화물, 액상 제제 및 그 제조 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070905 Year of fee payment: 4 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070905 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080905 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090905 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090905 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100905 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100905 Year of fee payment: 7 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100905 Year of fee payment: 7 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |